You are hereEvents
Cost-Effectiveness Of Cervical Cancer Screening Methods In Low- And Middle-Income Countries: A Systematic Review
The incidence of cervical cancer in low- and middle-income countries (LMICs) is five times higher than that observed in high-income countries (HICs). This discrepancy is largely attributed to the implementation of cytology-based screening programmes in HICs. However, due to reduced health system infrastructure requirements, HPV testing (self- and provider-collected), and visual inspection with acetic acid (VIA) have been proposed as alternatives that may be better suited to LMICs. This presentation will describe the methods, results and implications of a systematic review on the cost-effectiveness of cervical cancer screening methods in LMICs. Specific learning objectives that will be addressed are as follows:
- Describe the global burden of cervical cancer
- Compare the cost-effectiveness of cervical cancer screening methods in LMICs
- Identify the parameters that are driving cost-effectiveness ratios
- Describe areas of ongoing research
C2E2 Rounds are presented Mondays from 12:00 pm to 1:00 pm in room 700 of the VGH Research Pavilion, 828 West 10th Avenue, Vancouver, BC.